EP4063361A4 - Crystal forms of fused ring compound, and composition thereof, preparation method therefor and application thereof - Google Patents

Crystal forms of fused ring compound, and composition thereof, preparation method therefor and application thereof Download PDF

Info

Publication number
EP4063361A4
EP4063361A4 EP20890684.2A EP20890684A EP4063361A4 EP 4063361 A4 EP4063361 A4 EP 4063361A4 EP 20890684 A EP20890684 A EP 20890684A EP 4063361 A4 EP4063361 A4 EP 4063361A4
Authority
EP
European Patent Office
Prior art keywords
preparation
composition
application
fused ring
method therefor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP20890684.2A
Other languages
German (de)
French (fr)
Other versions
EP4063361A1 (en
Inventor
Qiaojun HE
Binhui CHEN
Lin Zheng
Qinjie WENG
Ding YE
Mingyong JIANG
Yi Gong
Xiaoling Wang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hangzhou Yusheng Medical Technology Co Ltd
Original Assignee
Hangzhou Yusheng Medical Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hangzhou Yusheng Medical Technology Co Ltd filed Critical Hangzhou Yusheng Medical Technology Co Ltd
Publication of EP4063361A1 publication Critical patent/EP4063361A1/en
Publication of EP4063361A4 publication Critical patent/EP4063361A4/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs
EP20890684.2A 2019-11-20 2020-11-18 Crystal forms of fused ring compound, and composition thereof, preparation method therefor and application thereof Pending EP4063361A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201911144271.3A CN110642854A (en) 2019-11-20 2019-11-20 Polycrystalline form of fused ring compound, composition, preparation method and application thereof
PCT/CN2020/129748 WO2021098716A1 (en) 2019-11-20 2020-11-18 Crystal forms of fused ring compound, and composition thereof, preparation method therefor and application thereof

Publications (2)

Publication Number Publication Date
EP4063361A1 EP4063361A1 (en) 2022-09-28
EP4063361A4 true EP4063361A4 (en) 2023-05-17

Family

ID=68995934

Family Applications (1)

Application Number Title Priority Date Filing Date
EP20890684.2A Pending EP4063361A4 (en) 2019-11-20 2020-11-18 Crystal forms of fused ring compound, and composition thereof, preparation method therefor and application thereof

Country Status (4)

Country Link
US (1) US20230029066A1 (en)
EP (1) EP4063361A4 (en)
CN (2) CN110642854A (en)
WO (1) WO2021098716A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110642854A (en) * 2019-11-20 2020-01-03 成都克莱蒙医药科技有限公司 Polycrystalline form of fused ring compound, composition, preparation method and application thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2870846B1 (en) * 2004-05-25 2006-08-04 Sanofi Synthelabo TETRAHYDROISOQUINOLYLSULFONAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE
ES2474147T3 (en) * 2008-05-30 2014-07-08 Amgen, Inc PI3 kinase inhibitors
CN102558185B (en) * 2010-12-09 2016-02-10 中国科学院上海药物研究所 Pyrido pyrrole triazine compound, Preparation Method And The Use
CN103788071A (en) * 2012-11-01 2014-05-14 中国人民解放军第二军医大学 N-(5-(quinolyl-6-yl) pyridyl-3-yl)benzsulfamide derivatives, and preparation method and treatment use thereof
CN104119317B (en) * 2014-07-25 2016-08-17 沈阳药科大学 Quinolines containing 1,2,3-triazole and its preparation method and application
CN104961725B (en) * 2015-06-18 2017-04-19 浙江大学 4-alpha, beta-unsaturated carboxamidoquinoline compounds and preparation and application
CN105859684B (en) * 2016-04-15 2017-03-22 四川赛诺唯新生物技术有限公司 Fused ring compound and preparation method, application and intermediate compound thereof
US20180000814A1 (en) * 2016-06-14 2018-01-04 Joseph Hacia Compositions and methods for the treatment of zellweger spectrum disorder
CN110642854A (en) * 2019-11-20 2020-01-03 成都克莱蒙医药科技有限公司 Polycrystalline form of fused ring compound, composition, preparation method and application thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
No further relevant documents disclosed *

Also Published As

Publication number Publication date
WO2021098716A1 (en) 2021-05-27
CN112225730A (en) 2021-01-15
US20230029066A1 (en) 2023-01-26
CN110642854A (en) 2020-01-03
EP4063361A1 (en) 2022-09-28

Similar Documents

Publication Publication Date Title
EP4043464A4 (en) Fused pyridone compound, and preparation method therefor and use thereof
EP3889154A4 (en) Heterocyclic compound intermediate, preparation method therefor and application thereof
EP3875458A4 (en) Diphenyl-like compound, intermediate thereof, preparation method therefor, pharmaceutical composition thereof and uses thereof
EP3896062A4 (en) Isoindoline compound, and preparation method, pharmaceutical composition, and application of isoindoline compound
EP3845531A4 (en) Substituted pyrazole fused ring derivative, preparation method therefor, and application thereof
EP3858830A4 (en) Crystal form of morpholino quinazoline compound, preparation method therefor and use thereof
EP3990445A4 (en) Heterocyclic compounds, preparation methods therefor, and methods of uses thereof
EP3842426A4 (en) Preparation method of pyrrolo-amino-pyridazinone compound and intermediate thereof
EP3992197A4 (en) Nitrogen-containing polycyclic fused ring compounds, and pharmaceutical composition thereof, preparation method therefor and application thereof
EP4008715A4 (en) Halogen substituted compound, and preparation method therefor and application thereof
EP3978482A4 (en) Isoxazoline compound, preparation method therefor and application thereof
EP4056551A4 (en) Crystal form i of curcumin derivative, preparation method therefor and application thereof
EP3805229A4 (en) Salt of fused ring pyrimidine compound, crystal form thereof and preparation method therefor and use thereof
EP4011867A4 (en) Crystal forms c and e of pyrazin-2(1h)-one compound and preparation method therefor
EP3929198A4 (en) Heterocyclic compound, pharmaceutical composition comprising same, preparation method therefor, and use thereof
EP4063361A4 (en) Crystal forms of fused ring compound, and composition thereof, preparation method therefor and application thereof
EP4005561A4 (en) Nano-micelle preparation of icaritin and preparation method therefor and application thereof
EP3964500A4 (en) Salt of diaminopyrimidine compounds, and solid form thereof, preparation method therefor and use thereof
EP3988546A4 (en) Salts of compound, crystalline forms thereof, preparation method therefor and application thereof
EP3920905A4 (en) Cannabinoid containing composition, methods of preparation and use thereof
EP3985009A4 (en) B crystal form of tetrahydrothienopyridine compound, preparation method therefor, composition and application
EP3741746A4 (en) Crystal form of oxopicolinamide derivative and preparation method therefor
EP3744712A4 (en) Crystalline forms of mesaconine and preparation method therefor
EP3736273A4 (en) Novel crystal form of acalabrutinib and preparation method and use thereof
EP4079724A4 (en) Fused ring compound and application thereof

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20220530

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20230418

RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 35/00 20060101ALI20230412BHEP

Ipc: A61K 31/5377 20060101ALI20230412BHEP

Ipc: C07D 413/14 20060101AFI20230412BHEP